Otamixaban HCl is an experimental injectable anticoagulant direct factor Xa inhibitor, that was investigated for the treatment for acute coronary syndrome. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial.
Molecular Weight:
482.97
CAS Number:
[409081-12-5]
Formula:
C25H27ClN4O4
Target:
Others|||Factor Xa
T71835
* VAT and and shipping costs not included. Errors and price changes excepted